,,,aaaccchh,,do readers here really think that experienced biotech investing firms and or fund managers with vast resources havent done DD and dont know this???,,,, really??,,I beg to differ and would say they are so far ahead of retail investors like ourselves that such papers add little value this late to the buffet as dutchfellow would say...all imo.  208 has been in the public research domain for years,,,,,and as noted you could buy it for research off the market which I assume was produced by the RVX manufacturing sub or subs!,,,,